Thursday, January 06, 2022 5:34:38 PM
Bottom line however is:
- This business may effectively fold or fail, no one should dispute that.
- This business may effectively proress normally for the next 2 years but within a year and one half or to, O/S could be (???) 4,000,000,000+ and pps at between $ 0,008 to $ 0,01 i.e a mC of more or less $35,000,000 (assuming a multiplier of 5, this would be supported by a year revenue of mor or less $7,000,000 ($1,750,000/mth).
Very simply put, we face 3 options:
- Leon fold and let both his creditors and shareholders empty hands
- Leon graduall grow the business as he did within the last year
- Leon optain financing and grants from govenments considering the market he aims at.
In the first case, we lose all we did bet (or invest) and hopefully we did not morgage the house buying in
In the second case shareholders with an AVG cost of 0,004 or less can run to the bank or keep the position grow over time
In the third case, Shareholders could make a killing
In any case, we, shareholders cannot do anything other than stay in and wait or sellout and go play somewhere else.
Patiently,
Roger
Recent GRST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:45:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:54:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:04:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:55:26 PM
- Form 1-A POS - • Edgar (US Regulatory) • 10/20/2023 07:29:40 PM
- Form 1-A POS - • Edgar (US Regulatory) • 08/29/2023 07:21:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:37:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 12:43:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 04:51:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 06:56:41 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM